What is the P/E ratio of Fermenta Biotech . - (Amalgamated)?

The latest standalone P/E ratio of Fermenta Biotech . - (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Fermenta Biotech . - (Amalgamated)?

The latest standalone P/B ratio of Fermenta Biotech . - (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Fermenta Biotech . - (Amalgamated)?

The 52-week high of Fermenta Biotech . - (Amalgamated) is Rs. and the 52-week low is Rs. .

Fermenta Biotech Ltd. - (Amalgamated) - Stock Valuation and Financial Performance

Name: Fermenta Biotech . - (Amalgamated)
Brand: Fermenta Biotech . - (Amalgamated)

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Fermenta Bio-Amalgam

Based on:

Data

M-Cap below 100cr DeciZen not available

Fermenta Biotech Ltd. - (Amalgamated) stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

0 Cr.

52-wk low:

52-wk high:

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Fermenta Bio-Amalgam:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	TTM
ROCE % ⓘ	5.1%	13.4%	16%	11.9%	3.3%	9%	3.8%	11.1%	8.4%	39.8%	-
Value Creation Index ⓘ	-0.6	0.0	0.1	-0.2	-0.8	-0.4	-0.7	-0.2	-0.4	1.8	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	35.1	48	64.4	101	100	125	129	147	159	292	292
Sales YoY Gr.	-	36.8%	34.2%	57.4%	-1.4%	25%	3.4%	13.8%	8.3%	83.2%	-
Adj EPS ⓘ	0.9	5.9	4.8	4.6	-0	3.6	0.6	5.5	4.7	36.6	0
YoY Gr.	-	527.7%	-19.3%	-4.2%	-100.2%	NA	-84.4%	889.3%	-15.5%	681.2%	-
BVPS (₹) ⓘ	30.8	36	32.5	38.4	39	44.3	44.4	51.1	56.7	97.5	0
Adj Net Profit ⓘ	0.8	4.7	8.7	8.3	0	6.5	1	10.1	8.5	66.5	0
Cash Flow from Ops. ⓘ	0	0	11.8	7.4	17.4	13.2	15	13.1	9.4	54.8	-
Debt/CF from Ops. ⓘ	0	0	1.7	5.1	2.6	3.2	2.5	2.9	4.6	0.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	26.5%	23.9%	31.2%	83.2%
Adj EPS ⓘ	50.2%	NA	302.7%	681.2%
BVPSⓘ	13.7%	20.1%	30%	72%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	TTM
Return on Equity % ⓘ	3.1	17.2	19.5	12.9	-0	8.8	1.3	11.9	8.9	48.7	0
Op. Profit Mgn % ⓘ	9.9	18.7	25	19.2	14.1	17.9	11.2	16.9	13	32.7	NAN
Net Profit Mgn % ⓘ	2.1	9.8	13.4	8.2	-0	5.2	0.8	6.9	5.3	22.8	0
Debt to Equity ⓘ	0.6	0.6	0.3	0.5	0.6	0.5	0.5	0.4	0.4	0.2	-
Working Cap Days ⓘ	217	160	156	153	188	175	179	174	202	158	0
Cash Conv. Cycle ⓘ	131	95	75	76	106	100	109	100	109	62	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Fermenta Biotech Ltd. - (Amalgamated)

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	292	-
BVPS (₹.) ⓘ	0	-
Reserves (₹ Cr.) ⓘ	155	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	- / -
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	0
Face Value (₹)	10
Industry PE ⓘ	48.8

Management X-Ray of Fermenta Bio-Amalgam:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Fermenta Bio-Amalgam

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Fermenta Bio-Amalgam

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Sales	35.11	48.02	64.44	101.41	100.02	125.01	129.25	147.10	159.23	291.71
Operating Expenses ⓘ	31.92	39.81	48.36	82.03	85.98	102.75	115.81	122.20	138.61	196.48
Manufacturing Costs	7.61	8.77	8.93	15.37	15.09	16.97	19.54	20.67	24.99	29.34
Material Costs	9.82	13.81	18.50	38.53	40.96	57.76	63.20	64.51	68.43	80.41
Employee Cost	5.41	6.38	10.17	13.70	15.74	14.69	17.48	20.36	22.59	34.06
Other Costs ⓘ	9.09	10.85	10.75	14.43	14.19	13.32	15.59	16.66	22.60	52.66
Operating Profit ⓘ	3.19	8.20	16.09	19.38	14.04	22.27	13.44	24.89	20.62	95.24
Operating Profit Margin (%)	9.1%	17.1%	25.0%	19.1%	14.0%	17.8%	10.4%	16.9%	12.9%	32.6%
Other Income ⓘ	2	0.30	1.13	3.89	1.75	2.21	0.10	2.70	2.32	8.47
Interest ⓘ	1.58	1.44	1.91	3.98	5.24	5.80	4.92	4.95	4.10	3.52
Depreciation ⓘ	1.71	2.31	2.95	6.01	7.11	8.04	6.73	6.47	6.72	7.70
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	1.90	4.75	12.36	13.27	3.44	10.64	1.89	16.18	12.12	92.48
Tax ⓘ	0.29	0.56	2.91	2.64	2.33	2.68	1.57	4.29	2.22	20.42
Profit After Tax	1.61	4.19	9.45	10.63	1.11	7.96	0.33	11.89	9.89	72.06
PAT Margin (%)	4.6%	8.7%	14.7%	10.5%	1.1%	6.4%	0.3%	8.1%	6.2%	24.7%
Adjusted EPS (₹)	2.0	5.2	5.2	5.9	0.6	4.5	0.2	6.7	5.6	40.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Equity and Liabilities
Shareholders Fund	25.31	29.49	59.20	69.83	70.94	78.41	78.62	90.51	100.40	172.66
Share Capital ⓘ	8.70	8.70	18.19	18.19	18.19	17.70	17.70	17.70	17.70	17.70
Reserves ⓘ	16.61	20.79	41	51.64	52.75	60.71	60.92	72.81	82.70	154.96
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	14.25	16.28	17.35	33.23	39.76	36.53	32.45	32.11	39.69	27.48
Long Term Debt	14.25	16.28	10.22	19.06	14.89	9.62	5.24	3.63	6.06	3.35
Short Term Debt	0	0	7.13	14.17	24.87	26.91	27.21	28.47	33.63	24.13
Trade Payables	3.46	3.84	7.94	12.42	14.61	18.21	15.08	18.04	27.19	38.86
Others Liabilities ⓘ	3.20	3.07	5.52	8.04	14.61	13.43	13.27	17.10	12.03	27.32
Total Liabilities ⓘ	46.21	52.68	90	123.52	139.91	146.59	139.43	157.75	179.32	266.32
Fixed Assets
Gross Block	29.50	33.38	44.27	78.92	108.77	110.17	115.36	117.42	129.45	91.04
Accumulated Depreciation	10.25	12.50	15.44	21.05	27.84	35.67	41.30	48.57	54.72	14.32
Net Fixed Assetsⓘ	19.25	20.89	28.82	57.88	80.93	74.49	74.06	68.85	74.74	76.72
CWIP ⓘ	0.77	5.69	13.78	6.32	1.67	1.30	1.01	5.36	4.19	3.50
Investmentsⓘ	1.87	1.87	1.87	1.87	1.87	1.87	1.87	1.87	1.87	0.42
Inventories	7.47	7.15	10.45	20.89	24.50	22.80	21.02	24.84	38.75	51.18
Trade Receivables	10.85	11.24	15.59	23.10	25	40.22	35.38	43.38	44.62	68.63
Cash Equivalents	2.60	3.19	10.36	6.04	0.97	0.43	0.34	0.84	1.14	30.53
Others Assetsⓘ	3.40	2.67	9.13	7.42	4.97	5.47	5.75	12.61	14.01	35.34
Total Assets ⓘ	46.21	52.68	90	123.52	139.91	146.59	139.43	157.75	179.32	266.32

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Cash Flow From Operating Activity ⓘ	11.81	7.43	17.41	13.16	15.03	13.13	9.43	54.84
PBT ⓘ	12.36	13.27	3.44	10.64	1.89	16.18	12.12	92.48
Adjustment ⓘ	4.16	8.62	12.43	14.02	12.08	10.54	14.16	13.08
Changes in Working Capital ⓘ	-3.4	-11.35	2.77	-10.63	3.49	-11.66	-12.78	-33.14
Tax Paid ⓘ	-1.32	-3.11	-1.22	-0.86	-2.43	-1.92	-4.07	-17.58
Cash Flow From Investing Activity ⓘ	-23.59	-24.95	-24.74	-4.37	-6.28	-8.28	-10.83	-18.58
Capex	-23.70	-25.99	-25.50	-4.48	-6.28	-8.18	-10.93	-18.69
Net Investments	0	0	0	0.09	-0.02	0	0	0
Others ⓘ	0.11	1.04	0.76	0.03	0.02	-0.10	0.10	0.11
Cash Flow From Financing Activityⓘ	18.95	13.20	2.25	-9.33	-8.84	-4.35	1.70	-16.18
Net Proceeds from Shares ⓘ	19.77	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	-5.68	-4.46	-0.88	-0.24	-13.20
Interest Paid ⓘ	-1.89	-4.48	-5.77	-5.70	-4.68	-4.57	-3.71	-2.98
Dividend Paid ⓘ	0	0	0	0	0	0	0	0
Others ⓘ	1.07	17.67	8.03	2.05	0.30	1.10	5.66	0
Net Cash Flow ⓘ	7.17	-4.32	-5.07	-0.54	-0.09	0.50	0.30	20.08

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18
Ratios
ROE (%)	6.76	15.68	21.47	16.48	1.58	10.66	0.42	14.06	10.36	52.78
ROCE (%)	9.49	14.51	22.86	18.5	7.75	13.87	5.76	17.23	11.92	55.42
Asset Turnover Ratio	0.84	0.99	0.92	0.97	0.78	0.9	0.93	1.01	0.95	1.31
PAT to CFO Conversion(x)	0	0	1.25	0.7	15.68	1.65	45.55	1.1	0.95	0.76
Working Capital Days
Receivable Days	112	82	74	68	86	93	104	96	100	71
Inventory Days	73	55	49	55	81	67	60	56	72	56
Payable Days	147	96	116	96	120	104	96	94	121	150

Fermenta Biotech Ltd. - (Amalgamated) Stock News

Fermenta Biotech Ltd. - (Amalgamated) FAQs

What is the share price of Fermenta Bio-Amalgam?

Company share prices are keep on changing according to the market conditions. The closing price of Fermenta Bio-Amalgam on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Fermenta Bio-Amalgam?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Fermenta Bio-Amalgam stood at ₹0.00.